Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.
Noronha NC, Mizukami A, Caliári-Oliveira C, Cominal JG, Rocha JLM, Covas DT, Swiech K, Malmegrim KCR. · 2019
Read Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. by Noronha NC, Mizukami A, Caliári-Oliveira C, Cominal JG, Rocha JLM, Covas DT, Swiech K, Malmegrim KCR. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6498654.txt.
Description
Noronha and co-authors review ways to prime mesenchymal stromal cells before they are used as therapy. These cells can calm immune responses and help repair tissue. They have been tested for immune, inflammatory, and degenerative diseases. Trial results so far have been promising but limited.
The review explains why the cells often fall short. Many die in harsh disease sites. Others vary by source, donor, and lab method. The authors then survey priming methods meant to strengthen them. These include cytokines, growth factors, low oxygen, drugs, and biomaterials. They also cover changed culture conditions. Readers get a map of each approach and its future use.
Catalog record
| CREATOR | Noronha NC, Mizukami A, Caliári-Oliveira C, Cominal JG, Rocha JLM, Covas DT, Swiech K, Malmegrim KCR. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 107 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |